Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia

go back to reference Clini EM, Beghe B, Fabbri LM. Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with copd. Am J Respir Crit Care Med. 2013;187:668–71.CrossRefPubMed Clini EM, Beghe B, Fabbri LM. Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with copd. Am J Respir Crit Care Med. 2013;187:668–71.CrossRefPubMed

go back to reference Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray, Abraham J, Ali MK, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami, Flaxman S, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin J, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KM, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray, Abraham J, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Forouzanfar MH, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL, Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KM, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Singh JA, Steenland K, Taylor JA, Thurston GD, Vavilala MS, Vos T, Wagner GR, Weinstock MA, Weisskopf MG, Wulf S, Murray. The state of us health, 1990–2010: Burden of diseases, injuries, and risk factors. Jama. 2013;310:591.CrossRefPubMed Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray, Abraham J, Ali MK, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami, Flaxman S, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin J, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KM, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray, Abraham J, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Forouzanfar MH, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL, Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KM, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Singh JA, Steenland K, Taylor JA, Thurston GD, Vavilala MS, Vos T, Wagner GR, Weinstock MA, Weisskopf MG, Wulf S, Murray. The state of us health, 1990–2010: Burden of diseases, injuries, and risk factors. Jama. 2013;310:591.CrossRefPubMed

go back to reference Fang X, Wang X, Bai C. Copd in china: The burden and importance of proper management. Chest. 2011;139:920–9.CrossRefPubMed Fang X, Wang X, Bai C. Copd in china: The burden and importance of proper management. Chest. 2011;139:920–9.CrossRefPubMed

go back to reference Maclay JD, MacNee W. Cardiovascular disease in copd: Mechanisms. Chest. 2013;143:798–807.CrossRefPubMed Maclay JD, MacNee W. Cardiovascular disease in copd: Mechanisms. Chest. 2013;143:798–807.CrossRefPubMed

go back to reference Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25:253–60.CrossRefPubMed Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25:253–60.CrossRefPubMed

go back to reference Konecny T, Park JY, Somers KR, Konecny D, Orban M, Soucek F, Parker KO, Scanlon PD, Asirvatham SJ, Brady PA, Rihal CS. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114:272–7.CrossRefPubMed Konecny T, Park JY, Somers KR, Konecny D, Orban M, Soucek F, Parker KO, Scanlon PD, Asirvatham SJ, Brady PA, Rihal CS. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114:272–7.CrossRefPubMed

go back to reference van Gestel AJ, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (copd). J Thorac Dis. 2010;2:215–22.PubMedPubMedCentral van Gestel AJ, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (copd). J Thorac Dis. 2010;2:215–22.PubMedPubMedCentral

go back to reference Passariello G, Peluso A, Moniello G, Maio A, Mazo S, Boccia G, Passariello N, Lettieri B, Chiefari M. Effect of autonomic nervous system dysfunction on sudden death in ischemic patients with anginal syndrome died during electrocardiographic monitoring in intensive care unit. Minerva Anestesiol. 2007;73:207–12.PubMed Passariello G, Peluso A, Moniello G, Maio A, Mazo S, Boccia G, Passariello N, Lettieri B, Chiefari M. Effect of autonomic nervous system dysfunction on sudden death in ischemic patients with anginal syndrome died during electrocardiographic monitoring in intensive care unit. Minerva Anestesiol. 2007;73:207–12.PubMed

go back to reference Andreas S, Haarmann H, Klarner S, Hasenfuss G, Raupach T. Increased sympathetic nerve activity in copd is associated with morbidity and mortality. Lung. 2014;192:235–41.CrossRefPubMed Andreas S, Haarmann H, Klarner S, Hasenfuss G, Raupach T. Increased sympathetic nerve activity in copd is associated with morbidity and mortality. Lung. 2014;192:235–41.CrossRefPubMed

go back to reference Takase B, Kato R, Arakawa K, Ohsuzu F, Ishihara M. Vagal nerve-mediated vasospasm-induced lethal ventricular fibrillation. J Electrocardiol. 2006;39:183–7.CrossRefPubMed Takase B, Kato R, Arakawa K, Ohsuzu F, Ishihara M. Vagal nerve-mediated vasospasm-induced lethal ventricular fibrillation. J Electrocardiol. 2006;39:183–7.CrossRefPubMed

go back to reference Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med. 2001;164:597–601.CrossRefPubMed Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med. 2001;164:597–601.CrossRefPubMed

go back to reference Adam O, Ukena C, Bohm M, Neuberger HR. Bidirectional ventricular tachycardia in a patient with exacerbation of chronic obstructive pulmonary disease. Clin Res Cardiol. 2012;101:851–2.CrossRefPubMed Adam O, Ukena C, Bohm M, Neuberger HR. Bidirectional ventricular tachycardia in a patient with exacerbation of chronic obstructive pulmonary disease. Clin Res Cardiol. 2012;101:851–2.CrossRefPubMed

go back to reference Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1982;285:916–8.CrossRef Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1982;285:916–8.CrossRef

go back to reference Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, Hnatkova K, Schomig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study. Lancet. 2006;367:1674–81.CrossRefPubMed Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, Hnatkova K, Schomig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study. Lancet. 2006;367:1674–81.CrossRefPubMed

go back to reference Zuern CS, Rizas K, Eick C, Sterz K, Gawaz M, Bauer A. Prevalence and predictors of severe autonomic failure in patients with insulin-dependent type 2 diabetes mellitus and coronary artery disease: Pilot study. J Electrocardiol. 2012;45:774–9.CrossRefPubMed Zuern CS, Rizas K, Eick C, Sterz K, Gawaz M, Bauer A. Prevalence and predictors of severe autonomic failure in patients with insulin-dependent type 2 diabetes mellitus and coronary artery disease: Pilot study. J Electrocardiol. 2012;45:774–9.CrossRefPubMed

go back to reference Barthel P, Bauer A, Muller A, Junk N, Huster KM, Ulm K, Malik M, Schmidt G. Reflex and tonic autonomic markers for risk stratification in patients with type 2 diabetes surviving acute myocardial infarction. Diabetes Care. 2011;34:1833–7.CrossRefPubMedPubMedCentral Barthel P, Bauer A, Muller A, Junk N, Huster KM, Ulm K, Malik M, Schmidt G. Reflex and tonic autonomic markers for risk stratification in patients with type 2 diabetes surviving acute myocardial infarction. Diabetes Care. 2011;34:1833–7.CrossRefPubMedPubMedCentral

go back to reference Bauer A, Morley-Davies A, Barthel P, Muller A, Ulm K, Malik M, Schmidt G. Bivariate phase-rectified signal averaging for assessment of spontaneous baroreflex sensitivity: Pilot study of the technology. J Electrocardiol. 2010;43:649–53.CrossRefPubMed Bauer A, Morley-Davies A, Barthel P, Muller A, Ulm K, Malik M, Schmidt G. Bivariate phase-rectified signal averaging for assessment of spontaneous baroreflex sensitivity: Pilot study of the technology. J Electrocardiol. 2010;43:649–53.CrossRefPubMed

go back to reference Lewis MJ, Annandale J, D’Silva LA, Davies RE, Reed Z, Lewis KE. Influence of long-term oxygen therapy on cardiac acceleration and deceleration capacity in hypoxic patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2011;31:258–65.CrossRefPubMed Lewis MJ, Annandale J, D’Silva LA, Davies RE, Reed Z, Lewis KE. Influence of long-term oxygen therapy on cardiac acceleration and deceleration capacity in hypoxic patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2011;31:258–65.CrossRefPubMed

go back to reference Yan-hong Xu, Xing-de Wang, Jia-jun Yang, Li Zhou, Yong-chao Pan. Changes of deceleration and acceleration capacity of heart rate in patients with acute hemispheric ischemic stroke. Clin Interv Aging. 2016;11:293–8. Yan-hong Xu, Xing-de Wang, Jia-jun Yang, Li Zhou, Yong-chao Pan. Changes of deceleration and acceleration capacity of heart rate in patients with acute hemispheric ischemic stroke. Clin Interv Aging. 2016;11:293–8.

go back to reference Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed

go back to reference Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith Jr SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. Acc/aha/esc 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the american college of cardiology/american heart association task force and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): Developed in collaboration with the european heart rhythm association and the heart rhythm society. Circulation. 2006;114:e385–484.CrossRefPubMed Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith Jr SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. Acc/aha/esc 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the american college of cardiology/american heart association task force and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): Developed in collaboration with the european heart rhythm association and the heart rhythm society. Circulation. 2006;114:e385–484.CrossRefPubMed

go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.CrossRefPubMedPubMedCentral Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.CrossRefPubMedPubMedCentral

go back to reference van Gestel AJ, Kohler M, Steier J, Sommerwerck U, Teschler S, Russi EW, Teschler H. Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease. Copd. 2012;9:160–5.CrossRefPubMed van Gestel AJ, Kohler M, Steier J, Sommerwerck U, Teschler S, Russi EW, Teschler H. Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease. Copd. 2012;9:160–5.CrossRefPubMed

go back to reference Marquis K, Maltais F. Poirier P: cardiovascular manifestations in patients with copd. Rev Mal Respir. 2008;25:663–73.CrossRefPubMed Marquis K, Maltais F. Poirier P: cardiovascular manifestations in patients with copd. Rev Mal Respir. 2008;25:663–73.CrossRefPubMed

go back to reference Roca M, Mitu F, Roca IC, Mihaescu T. Heart rate variations in chronic obstructive pulmonary disease. Rev Med Chir Soc Med Nat Iasi. 2013;117:616–22.PubMed Roca M, Mitu F, Roca IC, Mihaescu T. Heart rate variations in chronic obstructive pulmonary disease. Rev Med Chir Soc Med Nat Iasi. 2013;117:616–22.PubMed

go back to reference Grazzini M, Stendardi L, Gigliotti F, Scano G. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (copd). Respir Med. 2005;99:1403–12.CrossRefPubMed Grazzini M, Stendardi L, Gigliotti F, Scano G. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (copd). Respir Med. 2005;99:1403–12.CrossRefPubMed

go back to reference Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacretaz E. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009;54:530–6.CrossRefPubMed Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacretaz E. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009;54:530–6.CrossRefPubMed

go back to reference Van Gestel AJ, Kohler M, Clarenbach CF. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (copd). Discov Med. 2012;14:359–68.PubMed Van Gestel AJ, Kohler M, Clarenbach CF. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (copd). Discov Med. 2012;14:359–68.PubMed

go back to reference Handa R, Poanta L, Rusu D, Albu A. The role of heart rate variability in assessing the evolution of patients with chronic obstructive pulmonary disease. Rom J Intern Med. 2012;50:83–8.PubMed Handa R, Poanta L, Rusu D, Albu A. The role of heart rate variability in assessing the evolution of patients with chronic obstructive pulmonary disease. Rom J Intern Med. 2012;50:83–8.PubMed

go back to reference Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, Melga P, Viviani GL, Esposito K, Morganti R, Cortelli P. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21:69–78.CrossRefPubMed Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, Melga P, Viviani GL, Esposito K, Morganti R, Cortelli P. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21:69–78.CrossRefPubMed

go back to reference Gunduz H, Talay F, Arinc H, Ozyildirim S, Akdemir R, Yolcu M, Kanat M, Uyan C. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J. 2009;16:553–9.PubMed Gunduz H, Talay F, Arinc H, Ozyildirim S, Akdemir R, Yolcu M, Kanat M, Uyan C. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J. 2009;16:553–9.PubMed

go back to reference Chen WL, Chen GY, Kuo CD. Hypoxemia and autonomic nervous dysfunction in patients with chronic obstructive pulmonary disease. Respir Med. 2006;100:1547–53.CrossRefPubMed Chen WL, Chen GY, Kuo CD. Hypoxemia and autonomic nervous dysfunction in patients with chronic obstructive pulmonary disease. Respir Med. 2006;100:1547–53.CrossRefPubMed

go back to reference Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing DJ, the Antiarrhythmic Drug Evaluation Group (ADEG). Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Am Coll Cardiol. 1991;17:604–12.CrossRefPubMed Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing DJ, the Antiarrhythmic Drug Evaluation Group (ADEG). Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Am Coll Cardiol. 1991;17:604–12.CrossRefPubMed